Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amgen
Amgen
This Week in Biotech
Motley Fool
Sun, 09/8/13 - 11:09 am
Astex
Otsuka
Rockwell Medical
Theravance
GSK
Cytokinetics
Amgen
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 09/7/13 - 11:48 am
MiMedx
Cytokinetics
Amgen
Vivus
Onyx Sued by Investors Claiming Amgen Buyout Is Too Cheap
Bloomberg
Sat, 09/7/13 - 11:44 am
ONYX Pharmaceutical
Amgen
M&A
lawsuits
Amgen With Onyx Pharmaceuticals: Long-Term Analysis
Seeking Alpha
Wed, 09/4/13 - 01:15 pm
Amgen
ONYX Pharmaceuticals
M&A
Coherus inks $246M Baxter deal to develop Enbrel biosimilar
Fierce Biotech
Tue, 09/3/13 - 11:19 am
Coherus Biosciences
Baxter International
Enbrel
biosimilars
Amgen
Amgen, Cytokinetics Report Mixed Results For Heart Failure Drug
TheStreet.com
Tue, 09/3/13 - 10:39 am
Amgen
Cytokinetics
heart failure
Omecamtiv Mecarbil
Will Amgen's Purchase Of Onyx Prove To Be A Smart Move?
Seeking Alpha
Fri, 08/30/13 - 10:02 am
Amgen
M&A
ONYX Pharmaceuticals
Onyx spells out layoff policies as staffers brace for post-buyout cuts
Fierce Biotech
Thu, 08/29/13 - 11:14 am
layoffs
Amgen
ONYX Pharmaceuticals
M&A
Pharma Deal Volumes Rise as Early-Stage Drugs Draw Interest
WSJ Online
Thu, 08/29/13 - 09:43 am
M&A
ONYX Pharmaceuticals
Amgen
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
monoclonal antibodies
Roche
Herceptin
Rituxan
Avastin
GSK
Amgen
Eli Lilly
Bristol-Myers Squibb
Seattle Genetics
Adcetris
Kadcyla
bapineuzumab
Elan
JNJ
Pfizer
necitumumab
AbbVie
Humira
Is the Biotech Bubble About to Burst?
Motley Fool
Wed, 08/28/13 - 11:31 am
biotech
Cytokinetics
Amgen
Celgene
Astex
Amgen CEO wins kudos for bagging Onyx at reasonable price
Fierce Pharma
Wed, 08/28/13 - 10:47 am
Amgen
ONYX Pharmaceuticals
M&A
Pharma CEOs
Robert Bradway
These biotech names are ripe for takeover: Cramer
CNBC
Wed, 08/28/13 - 09:50 am
M&A
Amgen
ONYX Pharmaceuticals
Medivation
Astellas
Seattle Genetics
After sharp gains, Amgen slides on delayed criticism over Onyx deal
Marketwatch
Tue, 08/27/13 - 05:36 pm
Amgen
ONYX Pharmaceuticals
M&A
Will Amgen Stock Continue to Rise After Recent Acquisition?
Wall St. Cheat Sheet
Mon, 08/26/13 - 06:34 pm
Amgen
M&A
ONYX Pharmaceuticals
For once, buyer sees bigger gains than seller in Amgen-Onyx deal
Marketwatch
Mon, 08/26/13 - 12:02 pm
ONYX Pharmaceuticals
M&A
Amgen
Amgen to buy Onyx in deal worth $10.4 billion
Marketwatch
Mon, 08/26/13 - 09:03 am
Amgen
ONYX Pharmaceuticals
M&A
A Time to Test Biotechs' Strength
The Street
Sun, 08/25/13 - 11:31 am
Bluebird Bio
Epizyme
Intrexon
NanoString Technologies
LipoScience
Aratana
Heat Biologics
ONYX Pharmaceuticals
Amgen
Amgen Said to Be Near Agreement to Buy Onyx for $125 a Share
Bloomberg
Sun, 08/25/13 - 11:28 am
Amgen
ONYX Pharmaceuticals
M&A
What's the Big Deal About Onyx Anyway?
Motley Fool
Sat, 08/24/13 - 11:47 am
ONYX Pharmaceuticals
Amgen
M&A
Pages
« first
‹ previous
…
68
69
70
71
72
73
74
75
76
…
next ›
last »